Atrial Fibrillation, Risk Factors and Stenosis

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

MARCH 28, 2024

2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib. The primary safety endpoint was incidence of early onset (within seven days) primary adverse events; atrio-esophageal fistula (within 90 days); cardiac tamponade or perforation (within 30 days); and PV stenosis (within 12 months). Int J Stroke.

Atrial Fibrillation

Atrial Fibrillation AFIB Ablation Pulmonary

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm

Heart Rhythm Atrial Fibrillation Ablation Quality of Life

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1 Epidemiology of Atrial Fibrillation in the 21st Century.

Ablation

Ablation Atrial Fibrillation AFIB Heart Rhythm

Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank

Open Heart

SEPTEMBER 14, 2022

VHD incidence was determined using International Classification of Disease-10 codes for aortic stenosis (AS), aortic regurgitation (AR), mitral stenosis, mitral regurgitation (MR) and mitral valve prolapse. Clinical correlates of VHD included demographics, coronary artery disease, heart failure and atrial fibrillation.

Coronary Artery Disease

Coronary Artery Disease Bicuspid/Mitral Atrial Fibrillation Aortic

InterAtrial Block

EMS 12-Lead

AUGUST 25, 2024

Examples of cardio embolic stroke etiology include: 1. Atrial Fibrillation 2. Cardiomyopathy with mural thrombus 3. Patent Foramen Ovale 4. Severe calcific Aortic (valve) Stenosis 5. Mechanical prosthetic valve Severe carotid artery stenosis is also implicated in embolic stroke. We do have the ECG.

AFIB

AFIB Embolism Atrial Fibrillation RN

Abstract 4143007: Pericoronary fat attenuation index as a Novel Tool to predict the morbidity of new-onset atrial fibrillation in patients with myocardial infarction with nonobstructive coronary artery disease

Circulation

NOVEMBER 11, 2024

Background:Myocardial infarction with nonobstructive coronary artery disease (MINOCA) is a special syndrome with clear evidence of myocardial ischemia, but no clear stenosis of coronary artery imaging sign. The pericoronary fat attenuation index (FAI) could reflect the local coronary inflammation as a novel imaging marker.

Coronary Artery Disease

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Ischemia

Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement

Journal of the American Heart Association

MARCH 3, 2025

This study aimed to confirm the prognostic value of a novel angiographic microvascular resistance (AMR) index in patients undergoing transcatheter aortic valve replacement.Methods and ResultsWe prospectively included 335 patients with severe aortic stenosis who underwent transcatheter aortic valve replacement at Fuwai Hospital.

Aortic valve

Aortic valve Aortic Outcomes Myocardial Infarction

Long?Term Outcomes After Transcatheter Aortic Valve Implantation in Patients With Chronic Inflammatory Disease

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundChronic inflammatory disease (CID) accelerates atherosclerosis and the development of aortic stenosis. Patients with CID were predominantly female (60% versus 44%,P=0.002) and more often had pulmonary disorders (21% versus 13%,P=0.046) and atrial fibrillation (32% versus 20%,P=0.003). and 1.62, respectively).

Aortic valve

Aortic valve Aortic Outcomes Atrial Fibrillation

Abstract 114: “Failing” DAPT? Think Again

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, CTA head and neck 4 days later demonstrated 90 percent stenosis of the mid left V2 at the C3‐4 level and a 75‐90 percent stenosis of the left mid V2 segment at the C5‐6 level (hard and soft plaque in these areas). He also had moderate stenosis of the right V4 segment.

Stenosis

Stenosis Peripheral Arterial Disease Pacemaker Atherosclerosis

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

Abstract 223: Pre?Thrombectomy Diagnosis of Large Vessel Occlusion with Underlying Intracranial Atherosclerotic Disease

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Patients with ICAD more frequently presented with vascular risk factors. ICAD LVOS showed less frequent atrial fibrillation(AF)(4%vs31%,P=0.001), and lower baseline NIHSS(14vs17,P=0.002) compared to the non‐ICAD group. CTA collaterals scores were comparable between groups. Additional validation is warranted

Risk Factors

Risk Factors Stenosis Atrial Fibrillation Stroke

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Part 2: Empirical Studies in Cardiac Surgery; Risk Model Recommendations The Annals of Thoracic Surgery January 2022 David Shahian Social Risk Factors in Society of Thoracic Surgeons Risk Models.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Emergency Department Syncope Workup: After H and P, ECG is the Only Test Required for Every Patient.

Dr. Smith's ECG Blog

APRIL 8, 2015

Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade. heart auscultation (aortic stenosis); c. Until then, I consider any of these to be independent adverse risk factors. -- Finally, a dedicated syncope unit may improve evaluation and outcome (17). Good History and Physical exam, including a.

Arrhythmia

Arrhythmia Outcomes Risk Factors Chest Pain

The eye as a window to CVD: case series and literature review of retinal ischaemic perivascular lesion (RIPL)

The British Journal of Cardiology

FEBRUARY 4, 2025

We obtained a thorough medical history to identify risk factors and CVD. The most common risk factor was type 2 diabetes mellitus (90.9%), followed by hypertension (81.9%). and carotid artery stenosis in 8.3%. A diagnosis of arrhythmia was determined in 36.4%

Coronary Artery Disease

Coronary Artery Disease Risk Factors Cardiovascular Disease Stenosis

Cardiovascular Update

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

Late-breaking Clinical Trial Results from FARADISE, adMIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank

InterAtrial Block

Abstract 4143007: Pericoronary fat attenuation index as a Novel Tool to predict the morbidity of new-onset atrial fibrillation in patients with myocardial infarction with nonobstructive coronary artery disease

Angiographic Microvascular Resistance Is an Independent Predictor of Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement

Long?Term Outcomes After Transcatheter Aortic Valve Implantation in Patients With Chronic Inflammatory Disease

Abstract 114: “Failing” DAPT? Think Again

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

Abstract 223: Pre?Thrombectomy Diagnosis of Large Vessel Occlusion with Underlying Intracranial Atherosclerotic Disease

Published Research

Published Research

Emergency Department Syncope Workup: After H and P, ECG is the Only Test Required for Every Patient.

The eye as a window to CVD: case series and literature review of retinal ischaemic perivascular lesion (RIPL)

Stay Connected